Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Association of Body Mass Index and Serum Ferritin Level in Pediatrics With Beta-Thalassemia Major Disease Publisher



Yousefian S1, 2, 3 ; Aliabad GM4 ; Saleh R2, 3 ; Khedmati M2, 3
Authors
Show Affiliations
Authors Affiliations
  1. 1. Children and Adolescent Health Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. Child Growth and Development Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
  3. 3. Children's hospital, Isfahan University of Medical Sciences, Isfahan, Iran
  4. 4. Children' and adolescent health research center, Zahedan university of medical sciences, Zahedan, Iran

Source: Iranian Journal of Pediatric Hematology and Oncology Published:2022


Abstract

Background: Beta-thalassemia major is a type of inherited blood disease that results in variable outcomes such as severe anemia due to haemoglobin chains. Recurrent and lifelong blood transfusions as a treatment in betathalassemiamajor disease lead to iron deposition in various organs and cause the failure of multiple organs. Failureof affected organs leads to Body mass index (BMI) abnormality. This study aimed to evaluate the associationbetween BMI and serum ferritin level as a marker for iron overload.Materials and Methods: A cross-sectional study designed and conducted with total number of 740 paediatrics,with mean age about 14.2±8.7 years old and with beta-thalassemia major requiring recurrent blood transfusion.Patient information, including demographics, serum ferritin level and percentage of BMI, was recorded andanalysed by SPSS 25.0 and the statistical significant level, considered as 0.05.Results: A total number of 740 paediatrics with beta-thalassemia major disease (mean age about 14.2±8.7 years)were included to study to examine the association between serum ferritin level and their BMI. The total meanserum level of ferritin calculated about 3326 ± 3859 Nanogram/mililitter (ng/ml). Totally, 447 (60.4%) case ofthem had BMI percentile less than 5%, 274 (37.02%), 16 (2.16%) and 3 (0.4%) had BMI percentile 5%-85%,85%-95% and more than 95%. There was no relation between gender and serum ferritin levels. The relationshipbetween age and BMI has been positive (P=0.002). Finally, it resulted that there was a negative relationshipbetween the BMI percentile and mean serum ferritin levels in paediatrics with beta-thalassemia major (P=0.031).Conclusion: Frequent Blood transfusion is associated with elevated serum ferritin level in paediatrics with betathalassemiamajor disease and experiencing lower percentiles of BMI in these patients © 2022, Iranian Journal of Pediatric Hematology and Oncology. All Rights Reserved.
Related Docs
View other Related Docs
1. Evaluation of the Prevalence and Determinants of Iron Deficiency Anemia in a Sample of Preschool-Aged Children in Isfahan City, Iran, Journal of Isfahan Medical School (2017)
2. The Correlation Between the Cardiac and Hepatic Iron-Overload in Patients With Thalassemia Major Who Received Multiple Transfusion, Journal of Isfahan Medical School (2010)
3. Evaluation of Iron Status by Serum Ferritin Level in Iranian Carriers of Beta Thalassemia Minor, International Journal for Vitamin and Nutrition Research (2008)
4. T2-Weighted Cardiovascular Magnetic Resonance and Echocardiographic Arterial Elasticity Criteria for Monitoring Cardiac Siderosis in Patients With Beta-Thalassemia Major, Journal of Research in Medical Sciences (2022)
5. Efficacy and Safety of Iranian Made Deferasirox (Osveral®)In Iranian Major Thalassemic Patients With Transfusional Iron Overload: A One Year Prospective Multicentric Open-Label Non-Comparative Study, DARU, Journal of Pharmaceutical Sciences (2011)
6. Comparison of the Relationship Between Preoperative Hemoglobin Level and Acute Renal Failure in Patients Undergoing Noncardiac Surgery, Journal of Isfahan Medical School (2017)
7. Association Between Neutrophil Geletinase-Associated Lipocalin and Iron Deficiency Anemia in Children on Chronic Dialysis, Journal of Research in Medical Sciences (2014)
8. Prevalence of Anti Hcv Infection in Patients With Beta-Thalassemia in Isfahan-Iran, International Journal of Preventive Medicine (2012)
Experts (# of related papers)
View all Related Experts
Mohammad Reza Maracy (3)
Nafiseh Esmaeil (2)
Other Related Docs
9. Combined Therapy of Silymarin and Desferrioxamine in Patients With Β-Thalassemia Major: A Randomized Double-Blind Clinical Trial, Fundamental and Clinical Pharmacology (2009)
10. Household, Maternal, and Child Related Determinants of Hemoglobin Levels of Ethiopian Children: Hierarchical Regression Analysis, BMC Pediatrics (2019)
11. Magnetic Resonance Imaging Signal Reduction May Precede Volume Loss in the Pituitary Gland of Transfusion-Dependent Beta-Thalassemic Patients, Acta Radiologica (2010)
12. Prevalence and Severity of Anemia in Pediatric Hemodialysis Patients, Saudi Medical Journal (2007)
13. The Relation Between Body Iron Store and Ferritin, and Coronary Artery Disease, ARYA Atherosclerosis (2014)
14. Protective Role of Silymarin and Deferoxamine Against Iron Dextran-Induced Renal Iron Deposition in Male Rats, International Journal of Preventive Medicine (2013)
15. Assessment of Nutritional Status and Hematological Indices in Patients With Beta Thalassemia Major, Journal of Zanjan University of Medical Sciences and Health Services (2012)
16. Comparing Pituitary Mri Findings in Patients With Thalassemia With and Without Delayed Puberty, Journal of Isfahan Medical School (2011)
17. Effectiveness of Twice Weekly Iron Supplementation Compared With Daily Regimen in Reducing Anemia and Iron Deficiency During Pregnancy: A Randomized Trial in Iran, Journal of Research in Medical Sciences (2008)
18. Correlation of N-Terminal Pro-B-Type Natriuretic Peptide Levels and Cardiac Magnetic Resonance Imaging T2∗ in Patients With Β-Thalassaemia Major, Blood Transfusion (2016)
19. Assessment of the Relationship Between Iron Overload Based on Cardiac T2* Mri and Fragmented Qrs in Beta-Thalassemia Major Patients, Shiraz E Medical Journal (2020)
20. Malignancies in Patients With Β-Thalassemia Major and Β-Thalassemia Intermedia: A Multicenter Study in Iran, Pediatric Blood and Cancer (2009)
21. Double-Faced Cell-Mediated Immunity in Β-Thalassemia Major: Stimulated Phenotype Versus Suppressed Activity, Annals of Hematology (2009)
22. Diagnostic Performance and Discriminative Value of the Serum Ferritin Level for Predicting Preterm Labor, Journal of Research in Medical Sciences (2012)
23. Evaluating the Effect of Digital Game-Based Nutrition Education on Anemia Indicators in Adolescent Girls: A Randomized Clinical Trial, Food Science and Nutrition (2023)
24. Globin Gene Mutations in Isfahan Province, Iran, Hemoglobin (2014)
25. A Study on Body Mass Index, Blood Pressure, and Red Blood Cell Indices in New Entering Students of the University of Isfahan, International Journal of Preventive Medicine (2011)
26. A Randomized Double-Blind, Placebo-Controlled Study of Therapeutic Effects of Silymarin in Β-Thalassemia Major Patients Receiving Desferrioxamine, European Journal of Haematology (2013)
27. Prevalence of Minor Β-Thalassemia Based on Rbc Indices Among Final Suspected Individuals in Premarital Screening Program Referred to Genetic Laboratories, International Journal of Hematology-Oncology and Stem Cell Research (2010)
28. Prevalence and Severity of Anemia in Pediatric Hemodialysis Patients, a Single Center Study, Journal of Research in Medical Sciences (2006)
29. Prevalence of Depression in Patients With Β-Thalassemia As Assessed by the Beck's Depression Inventory, Hemoglobin (2014)
30. Prevalence of Anemia According to Some Hematological Parameters Among Reproductive-Age Females in Kermanshah, Western Iran, Journal of Nutrition and Food Security (2019)
31. Prevalence of Microcytic Anemia Among Newborn Infants From Baharloo Hospital, Tehran, Iran, Tehran University Medical Journal (2021)
32. Changes in Bone Turnover, Inflammatory, Oxidative Stress, and Metabolic Markers in Women Consuming Iron Plus Vitamin D Supplements: A Randomized Clinical Trial, Biological Trace Element Research (2021)
33. The Effect of Combination Iron Chelating Agents on Reducing the Severity Grading of Heart and Liver Iron Overload in Β-Thalassemia Patients, Iranian Journal of Pediatric Hematology and Oncology (2019)
34. Hypercoagulopathy and Serum “Natural Antithrombotic Factors” in Beta-Thalassemia Major, Journal of Isfahan Medical School (2008)
35. Teff Consumption and Anemia in Pregnant Ethiopian Women: A Case–Control Study, European Journal of Nutrition (2019)
36. Detection of Ivsii-1 Mutation of Beta Globin Gene in Patients With Thalassemia Minor Using High-Resolution Melting Analysis, Journal of Isfahan Medical School (2016)
37. Comparison of Iron Chelation Effects of Deferoxamine, Deferasirox, and Combination of Deferoxamine and Deferiprone on Liver and Cardiac T2* Mri in Thalassemia Maior, Caspian Journal of Internal Medicine (2017)
38. The Effect of Simultaneous Administration of Zinc Sulfate and Ferrous Sulfate in the Treatment of Anemic Pregnant Women, Journal of Research in Medical Sciences (2005)
39. The Pros and Cons of the Fourth Revision of Thalassaemia Screening Programme in Iran, Journal of Medical Screening (2017)
40. Determination of the Need for Prenatal Diagnosis in Carriers of Alpha Thalassemia, Journal of Isfahan Medical School (2013)
41. Influence of Average Annual Mean Serum Ferritin Levels on Left Ventricular Function in Patients With Β Thalassemia, Acta Medica Iranica (2020)
42. Discrimination of Beta-Thalassemia Minor and Iron Deficiency Anemia by Screening Test for Red Blood Cell Indices, Turkish Journal of Medical Sciences (2012)
43. Serum Levels of Tgfβ, Il-10, Il-17, and Il-23 Cytokines in Β-Thalassemia Major Patients: The Impact of Silymarin Therapy, Immunopharmacology and Immunotoxicology (2014)
44. Iron and Zinc Nutritional and Biochemical Status and Their Relationship Among Child Bearing Women in Marand Province, Pakistan Journal of Nutrition (2007)
45. Can Couples With Mcv≥80, Mch<26, Hba2<3.2, Hbf<3 Be Classified As Low-Risk Β-Thalassemia Group?, Journal of Pediatric Hematology/Oncology (2019)
46. Prevalence, Years Lived With Disability, and Trends in Anaemia Burden by Severity and Cause, 1990–2021: Findings From the Global Burden of Disease Study 2021, The Lancet Haematology (2023)